Chronic ketamine use increases serum levels of brain-derived neurotrophic factor. (Q48304534)

10 February 2018

title

Chronic ketamine use increases serum levels of brain-derived neurotrophic factor. (English)

1 reference

10 February 2018

5

Carlo Caltagirone

1 reference

10 February 2018

Valerio Ricci

1

1 reference

10 February 2018

Giovanni Martinotti

2

1 reference

10 February 2018

Francesca Gelfo

3

1 reference

10 February 2018

Federico Tonioni

4

1 reference

10 February 2018

Pietro Bria

6

1 reference

10 February 2018

Francesco Angelucci

7

1 reference

10 February 2018

publication date

14 December 2010

1 reference

10 February 2018

number of pages

6

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

10 February 2018

volume

215

1 reference

10 February 2018

issue

1

1 reference

10 February 2018

page(s)

143-148

1 reference

10 February 2018

https://scigraph.springernature.com/pub.10.1007/s00213-010-2121-3

exact match

0 references

cites work

Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

Chronic amphetamine treatment reduces NGF and BDNF in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

Chronic heroin and cocaine abuse is associated with decreased serum concentrations of the nerve growth factor and brain-derived neurotrophic factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

Reduced serum concentrations of nerve growth factor, but not brain-derived neurotrophic factor, in chronic cannabis abusers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

Effects of psychostimulants on neurotrophins implications for psychostimulant-induced neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

Expression of mRNA of neurotrophic factors and their receptors are significantly altered after subchronic ketamine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

Antidepressant effects of ketamine in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

Decreased brain-derived neurotrophic factor in medicated and drug-free bipolar patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

Antiapoptotic and neurotrophic effects of antidepressants: a review of clinical and experimental studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

The assessment of anxiety states by rating

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

The psychotropic effect of ketamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

The effects of sub-anaesthetic doses of ketamine on memory, cognitive performance and subjective experience in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

Long-term potentiation in the hippocampus involves activation of N-methyl-D-aspartate receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

Prolonged exposure to ketamine increases brain derived neurotrophic factor levels in developing rat brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

Ketamine-induced hyperlocomotion associated with alteration of presynaptic components of dopamine neurons in the nucleus accumbens of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

Effects of ketamine on dopamine metabolism during anesthesia in discrete brain regions in mice: comparison with the effects during the recovery and subanesthetic phases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

Peptides crossing the blood-brain barrier: some unusual observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

High concentrations of plasma brain-derived neurotrophic factor in methamphetamine users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

Effect of 5-HT3 receptor antagonist MDL 72222 on behaviors induced by ketamine in rats and mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

Nerve Growth Factor: Structure, Function and Therapeutic Implications for Alzheimers Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

Activity-dependent release of brain-derived neurotrophic factor underlies the neuroprotective effect of N-methyl-D-aspartate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

Brain-derived neurotrophic factor expression is increased in the rat amygdala, piriform cortex and hypothalamus following repeated amphetamine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

TrkB signalling pathways in LTP and learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

Contributions of quisqualate and NMDA receptors to the induction and expression of LTP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

Transport of brain-derived neurotrophic factor across the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

Neurotrophins and neuronal plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

Synaptic activity controls dendritic spine morphology by modulating eEF2-dependent BDNF synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

Prolonged effect of an anesthetic dose of ketamine on behavioral despair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

Ketamine blocks the induction of LTP at the lateral entorhinal cortex-dentate gyrus synapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2121-3

Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine.

21 January 2018

1 reference

12 December 2020

Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.

1 reference

12 December 2020

Enhanced survival and morphological features of basal forebrain cholinergic neurons in vitro: role of neurotrophins and other potential cortically derived cholinergic trophic factors

1 reference

12 December 2020

Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus.

1 reference

12 December 2020

The role of neuronal growth factors in neurodegenerative disorders of the human brain

1 reference

12 December 2020

Ketamine: behavioral effects of subanesthetic doses

1 reference

12 December 2020

Acute effects of ketamine in the holeboard, the elevated-plus maze, and the social interaction test in Wistar rats.

1 reference

12 December 2020

The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate

1 reference

12 December 2020

10.1007/S00213-010-2121-3

Identifiers

DOI

1 reference

10 February 2018

PubMed ID

21161184

1 reference

10 February 2018